| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 4.35e-07 | 8 | 180 | 4 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.29e-06 | 10 | 180 | 4 | GO:0140999 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 2.76e-05 | 20 | 180 | 4 | GO:0042800 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 4.71e-05 | 143 | 180 | 8 | GO:0017124 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 1.71e-04 | 129 | 180 | 7 | GO:0035591 | |
| GeneOntologyMolecularFunction | protein domain specific binding | SHANK1 DOCK4 LILRB2 IRF3 E2F4 TACC2 BCAR1 PRRT2 CBLB MECP2 NCOR1 PTPN12 SHANK2 MAVS ABI2 TNKS1BP1 FKBP8 GNAS SON | 3.62e-04 | 875 | 180 | 19 | GO:0019904 |
| GeneOntologyMolecularFunction | synaptic receptor adaptor activity | 4.79e-04 | 4 | 180 | 2 | GO:0030160 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 6.54e-04 | 44 | 180 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 6.73e-04 | 320 | 180 | 10 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 7.76e-04 | 326 | 180 | 10 | GO:0001217 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TRERF1 BCL9L SATB2 ZNF142 ZNF219 CDK12 ZNF629 APBB1 SOX18 IRF3 CRTC1 E2F4 BARX2 MECP2 RAX PWWP2A KMT2C ZNF263 KMT2D MAVS PELP1 NFATC2IP CTCF MZF1 TOX3 HCFC1 MED12 NOTCH3 ZNF574 | 1.04e-05 | 1390 | 180 | 29 | GO:0045944 |
| GeneOntologyCellularComponent | adherens junction | CDCA3 DLG5 MTSS1 CAMSAP3 ZYX TGM1 ABI2 AJM1 NECTIN2 TNKS1BP1 PLEKHA7 | 2.65e-06 | 212 | 182 | 11 | GO:0005912 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 4.07e-06 | 75 | 182 | 7 | GO:0035097 | |
| GeneOntologyCellularComponent | zonula adherens | 3.52e-05 | 8 | 182 | 3 | GO:0005915 | |
| GeneOntologyCellularComponent | anchoring junction | CDCA3 DLG5 SCARF2 MTSS1 CAMSAP3 DBN1 BCAR1 ZYX TGM1 PTPN12 XIRP2 ABI2 MRC2 AJM1 LPP NECTIN2 TNKS1BP1 FBLIM1 PLEKHA7 WNK4 APBB1IP ATP6V0A2 | 4.28e-05 | 976 | 182 | 22 | GO:0070161 |
| GeneOntologyCellularComponent | methyltransferase complex | 4.49e-05 | 108 | 182 | 7 | GO:0034708 | |
| GeneOntologyCellularComponent | Set1C/COMPASS complex | 3.34e-04 | 16 | 182 | 3 | GO:0048188 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 5.68e-04 | 19 | 182 | 3 | GO:0098871 | |
| Domain | FYrich_C | 7.84e-06 | 5 | 174 | 3 | IPR003889 | |
| Domain | FYrich_N | 7.84e-06 | 5 | 174 | 3 | IPR003888 | |
| Domain | FYRC | 7.84e-06 | 5 | 174 | 3 | SM00542 | |
| Domain | FYRN | 7.84e-06 | 5 | 174 | 3 | SM00541 | |
| Domain | FYRN | 7.84e-06 | 5 | 174 | 3 | PF05964 | |
| Domain | FYRC | 7.84e-06 | 5 | 174 | 3 | PF05965 | |
| Domain | FYRC | 7.84e-06 | 5 | 174 | 3 | PS51543 | |
| Domain | FYRN | 7.84e-06 | 5 | 174 | 3 | PS51542 | |
| Domain | Post-SET_dom | 1.21e-05 | 16 | 174 | 4 | IPR003616 | |
| Domain | PostSET | 1.21e-05 | 16 | 174 | 4 | SM00508 | |
| Domain | POST_SET | 1.21e-05 | 16 | 174 | 4 | PS50868 | |
| Domain | Znf_C2H2-like | TRERF1 BNC2 ZBTB2 ZNF142 ZNF219 ZNF629 ZBTB9 ZNF205 ZNF318 ZNF414 ZNF263 ZNF276 ZNF608 CTCF MZF1 ZFR2 ZNF358 ZFHX2 ZNF687 ZNF574 | 5.42e-05 | 796 | 174 | 20 | IPR015880 |
| Domain | ZnF_C2H2 | TRERF1 BNC2 ZBTB2 ZNF142 ZNF219 ZNF629 ZBTB9 ZNF205 ZNF318 ZNF414 ZNF263 ZNF276 ZNF608 CTCF MZF1 ZFR2 ZNF358 ZFHX2 ZNF687 ZNF574 | 6.66e-05 | 808 | 174 | 20 | SM00355 |
| Domain | N-CoR_GPS2_interact | 8.63e-05 | 2 | 174 | 2 | IPR031557 | |
| Domain | GPS2_interact | 8.63e-05 | 2 | 174 | 2 | PF15784 | |
| Domain | AT_hook | 1.08e-04 | 27 | 174 | 4 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.08e-04 | 27 | 174 | 4 | IPR017956 | |
| Domain | Znf_C2H2 | TRERF1 BNC2 ZBTB2 ZNF142 ZNF219 ZNF629 ZBTB9 ZNF205 ZNF414 ZNF263 ZNF276 ZNF608 CTCF MZF1 ZFR2 ZNF358 ZFHX2 ZNF687 ZNF574 | 1.89e-04 | 805 | 174 | 19 | IPR007087 |
| Domain | SH3 | 1.97e-04 | 216 | 174 | 9 | PS50002 | |
| Domain | SH3_domain | 2.26e-04 | 220 | 174 | 9 | IPR001452 | |
| Domain | zf-C2H2 | TRERF1 BNC2 ZBTB2 ZNF142 ZNF219 ZNF629 ZBTB9 ZNF205 ZNF414 ZNF263 ZNF276 CTCF MZF1 ZNF358 ZFHX2 ZNF687 ZNF574 | 2.67e-04 | 693 | 174 | 17 | PF00096 |
| Domain | Homeodomain-like | TRERF1 SEMA6C SATB2 BARX2 RAX NCOR1 NCOR2 NKX2-4 SSH3 ZFHX2 HOMEZ | 2.91e-04 | 332 | 174 | 11 | IPR009057 |
| Domain | RA | 3.40e-04 | 36 | 174 | 4 | PF00788 | |
| Domain | ZINC_FINGER_C2H2_2 | TRERF1 BNC2 ZBTB2 ZNF142 ZNF219 ZNF629 ZBTB9 ZNF205 ZNF414 ZNF263 ZNF276 ZNF608 CTCF MZF1 ZNF358 ZFHX2 ZNF687 ZNF574 | 3.41e-04 | 775 | 174 | 18 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | TRERF1 BNC2 ZBTB2 ZNF142 ZNF219 ZNF629 ZBTB9 ZNF205 ZNF414 ZNF263 ZNF276 ZNF608 CTCF MZF1 ZNF358 ZFHX2 ZNF687 ZNF574 | 3.51e-04 | 777 | 174 | 18 | PS00028 |
| Domain | RA | 3.78e-04 | 37 | 174 | 4 | PS50200 | |
| Domain | AT_hook | 4.07e-04 | 16 | 174 | 3 | PF02178 | |
| Domain | RA_dom | 5.12e-04 | 40 | 174 | 4 | IPR000159 | |
| Domain | SET | 5.63e-04 | 41 | 174 | 4 | PF00856 | |
| Domain | SET | 8.75e-04 | 46 | 174 | 4 | SM00317 | |
| Domain | SH3 | 9.65e-04 | 216 | 174 | 8 | SM00326 | |
| Domain | EPHD | 1.07e-03 | 22 | 174 | 3 | PS51805 | |
| Domain | SET_dom | 1.20e-03 | 50 | 174 | 4 | IPR001214 | |
| Domain | SET | 1.20e-03 | 50 | 174 | 4 | PS50280 | |
| Domain | OSR1_C | 1.26e-03 | 6 | 174 | 2 | PF12202 | |
| Domain | Kinase_OSR1/WNK_CCT | 1.26e-03 | 6 | 174 | 2 | IPR024678 | |
| Domain | - | 1.38e-03 | 283 | 174 | 9 | 1.10.10.60 | |
| Domain | SAM | 1.39e-03 | 88 | 174 | 5 | SM00454 | |
| Domain | HMG_box | 1.49e-03 | 53 | 174 | 4 | PF00505 | |
| Domain | HMG | 1.60e-03 | 54 | 174 | 4 | SM00398 | |
| Domain | SANT_dom | 1.76e-03 | 26 | 174 | 3 | IPR017884 | |
| Domain | SAM_DOMAIN | 1.95e-03 | 95 | 174 | 5 | PS50105 | |
| Pathway | REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX | 2.11e-05 | 7 | 121 | 3 | M27899 | |
| Pathway | PID_ECADHERIN_STABILIZATION_PATHWAY | 2.51e-05 | 41 | 121 | 5 | M232 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.83e-05 | 42 | 121 | 5 | M48018 | |
| Pathway | REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME | 1.66e-04 | 13 | 121 | 3 | M29766 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TRERF1 SETD1A BCAR1 C6orf132 NCOR1 NCOR2 RASAL3 AEBP1 XIRP2 YLPM1 ATF7IP2 AFF1 SPEN PLEKHA7 NEURL4 WNK4 WNK2 ARAP1 SON TMEM139 | 2.40e-13 | 430 | 186 | 20 | 35044719 |
| Pubmed | SEMA6C SETD1A RALGDS DLG5 SATB2 CDK12 MTSS1 FNBP4 CRTC1 SMG5 KMT2C UBE2O ZNF608 MRC2 KBTBD11 IGSF9 TNKS1BP1 WNK2 ZNF687 ARAP1 HOMEZ | 1.23e-12 | 529 | 186 | 21 | 14621295 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA6C SETD1A KMT2B KIAA0513 CDK12 EMID1 SMG5 ANO8 MXRA7 C6orf132 PRR12 NCOR1 KMT2C NCOR2 ZNF263 KMT2D ZNF276 SHANK2 NISCH KBTBD11 TNKS1BP1 SLC45A1 SPEN MMP17 HCFC1 MED12 WNK2 ZNF687 ARAP1 | 1.59e-12 | 1105 | 186 | 29 | 35748872 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TRERF1 EME1 KMT2B RAPH1 CDK12 CAMSAP3 FNBP4 ZC3H18 ZNF318 DBN1 MECP2 ZYX SMTN NCOR1 NCOR2 KMT2D YLPM1 AFF1 CCAR2 TNKS1BP1 SPEN ZNF687 HOMEZ SON | 5.20e-12 | 774 | 186 | 24 | 15302935 |
| Pubmed | TRERF1 BCL9L SETD1A SATB2 KMT2B CCDC174 ZNF629 ZBTB9 PPP1R13B IRF3 ZC3H18 ZNF318 SMG5 DBN1 PRR12 NCOR1 KMT2C NCOR2 UBE2O KMT2D ZNF608 NKX2-4 CTCF PRCC G3BP2 DGKK YLPM1 CCAR2 SPEN HCFC1 ZNF687 HOMEZ | 6.47e-12 | 1429 | 186 | 32 | 35140242 | |
| Pubmed | SHANK1 TRERF1 KIF13B CASC3 ZNF219 HCN3 CAMSAP3 SRPK2 ZNF318 DBN1 NCOR1 NCOR2 ZNF263 UBE2O SHANK2 PELP1 CTCF ABI2 NISCH G3BP2 YLPM1 MACF1 CCAR2 KIF2A NEURL4 WNK2 | 1.37e-11 | 963 | 186 | 26 | 28671696 | |
| Pubmed | TRERF1 SATB2 KMT2B RAPH1 CAMSAP3 ZBTB9 CRTC1 ZNF318 PRR12 NCOR1 NCOR2 KMT2D ZNF608 ATF7IP2 TNKS1BP1 MED12 ZNF687 HOMEZ | 1.43e-11 | 418 | 186 | 18 | 34709266 | |
| Pubmed | SETD1A KMT2B RAPH1 CDK12 FNBP4 APBB1 PPP1R13B ZNF318 DBN1 ZYX NCOR1 KMT2C UBE2O KMT2D LPP YLPM1 TNKS1BP1 SPEN HCFC1 MED12 | 2.03e-11 | 549 | 186 | 20 | 38280479 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 BCL9L SETD1A SATB2 KMT2B ZBTB9 PRR12 NCOR1 KMT2C NCOR2 ZNF263 KMT2D ZNF608 SPEN MED12 HOMEZ | 8.82e-11 | 351 | 186 | 16 | 38297188 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SATB2 ZBTB2 KIAA0513 RBL2 IRF3 SRPK2 SMG5 LENG9 MECP2 TGM1 NCOR1 NCOR2 KMT2D TXNDC5 PELP1 NFATC2IP ABI2 NISCH RECQL4 CCAR2 SPEN HCFC1 NOTCH3 | 2.56e-10 | 857 | 186 | 23 | 25609649 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DOCK4 KIF13B DLG5 CCDC174 LRSAM1 ZNF629 PPP1R13B TACC2 ZC3H18 ZNF318 BCAR1 NCOR1 NCOR2 NFATC2IP MACF1 TNKS1BP1 GNAS SPEN ZNF574 | 4.95e-10 | 588 | 186 | 19 | 38580884 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 KIF13B CASC3 DLG5 RAPH1 CAMSAP3 ZNF629 APBB1 CRTC1 BCAR1 ARHGEF17 ZYX C6orf132 LPP NECTIN2 MACF1 TNKS1BP1 DCLK2 KIF2A GNAS PLEKHA7 WNK4 | 1.60e-09 | 861 | 186 | 22 | 36931259 |
| Pubmed | BCL9L CASC3 DLG5 KMT2B CDK12 CAMSAP3 CRTC1 SRPK2 ZNF318 MECP2 C6orf132 FBXL6 PRR12 PWWP2A KMT2C SHANK2 CTCF ABI2 MACF1 OS9 KIF2A FKBP8 SPEN PLEKHA7 MED12 ZNF687 ATP6V0A2 SON ZNF574 | 2.00e-09 | 1497 | 186 | 29 | 31527615 | |
| Pubmed | TROAP CDK12 CAMSAP3 TACC2 BCAR1 ZYX NCOR1 PTPN12 MAVS NFATC2IP SSH3 TNKS1BP1 SPEN HCFC1 ZNF687 SON ZNF574 | 2.17e-09 | 503 | 186 | 17 | 16964243 | |
| Pubmed | 3.06e-09 | 43 | 186 | 7 | 33472061 | ||
| Pubmed | 3.18e-09 | 12 | 186 | 5 | 27563068 | ||
| Pubmed | KMT2B CDK12 RNPC3 FNBP4 PPP1R13B CBLB ZYX NCOR1 NCOR2 KMT2D PTPN12 PELP1 YLPM1 AFF1 MACF1 OS9 SON TMEM139 | 3.65e-09 | 591 | 186 | 18 | 15231748 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | BORCS6 DLG5 ZNF318 SMTN PRR12 NCOR1 NCOR2 KRBA1 KMT2D CCAR2 SPEN | 5.15e-09 | 184 | 186 | 11 | 32908313 |
| Pubmed | TRERF1 SATB2 KMT2B CCDC174 ZNF629 ZBTB9 ZNF318 ZNF414 MECP2 ZYX PRR12 NCOR1 KMT2C NCOR2 KMT2D TXNDC5 G3BP2 CCAR2 KIF2A SPEN HCFC1 MED12 ZNF687 HOMEZ | 6.35e-09 | 1103 | 186 | 24 | 34189442 | |
| Pubmed | CDCA3 RAPH1 DUSP4 CAMSAP3 PPP1R13B BCAR1 ZYX NCOR1 NCOR2 KMT2D PTPN12 TXNDC5 ABI2 SSH3 LPP NECTIN2 YLPM1 PHLPP1 CCAR2 FKBP8 PLEKHA7 CTDSPL NEURL4 | 1.17e-08 | 1049 | 186 | 23 | 27880917 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | CDCA3 DLG5 RAPH1 PPP1R13B DBN1 ZYX C6orf132 SHANK2 MAVS SSH3 LPP NECTIN2 MACF1 TNKS1BP1 PLEKHA7 HCFC1 NOTCH3 | 1.21e-08 | 565 | 186 | 17 | 25468996 |
| Pubmed | TRERF1 BNC2 SATB2 ZNF219 ZNF205 IRF3 E2F4 ZNF318 LENG9 RAX ZYX NCOR1 ZNF263 KRBA1 NKX2-4 CTCF LPP TOX3 FBLIM1 ZNF687 | 1.57e-08 | 808 | 186 | 20 | 20412781 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EME1 ZNF219 KMT2B FNBP4 ZNF629 ZNF205 ZC3H18 ZNF318 MECP2 FBXL6 PRR12 PWWP2A NCOR1 KMT2C NCOR2 KMT2D ZNF276 PELP1 CTCF YLPM1 SPEN HCFC1 ZNF687 HOMEZ SON | 3.09e-08 | 1294 | 186 | 25 | 30804502 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | KIF13B SETD1A ZC3H18 FBXL6 NCOR1 KMT2D PRCC YLPM1 TNKS1BP1 SPEN HCFC1 MED12 ZNF687 | 4.49e-08 | 341 | 186 | 13 | 32971831 |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | BCL9L ZBTB2 PRR12 NCOR1 NCOR2 NECTIN2 YLPM1 AIPL1 PLEKHA7 NOTCH3 | 5.22e-08 | 180 | 186 | 10 | 35198878 |
| Pubmed | 5.45e-08 | 8 | 186 | 4 | 22266653 | ||
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 5.45e-08 | 8 | 186 | 4 | 23130995 | |
| Pubmed | 9.77e-08 | 9 | 186 | 4 | 22665483 | ||
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 1.01e-07 | 22 | 186 | 5 | 26886794 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CASC3 CAMSAP3 FNBP4 FBXL17 SRPK2 BCAR1 MAP3K12 ANO8 KMT2C NCOR2 SHANK2 ZNF608 LPP NECTIN2 TOX3 ZFHX2 AFF1 MACF1 OS9 IGSF9 DCLK2 GNAS CTDSPL WNK2 NOTCH3 ARAP1 | 1.17e-07 | 1489 | 186 | 26 | 28611215 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SATB2 TACC2 ZNF318 DBN1 ZYX SMTN NCOR1 NCOR2 MAVS ZNF608 PRCC LPP TNKS1BP1 HCFC1 | 1.40e-07 | 444 | 186 | 14 | 34795231 |
| Pubmed | TRERF1 BCL9L ZBTB9 PRR12 NCOR1 KMT2D ZNF608 NFATC2IP YLPM1 HCFC1 MED12 | 2.41e-07 | 268 | 186 | 11 | 33640491 | |
| Pubmed | CDCA3 DLG5 RAPH1 CDK12 CCDC174 APBB1 MECP2 SMTN CTCF PRCC NECTIN2 MACF1 MED12 ZNF687 | 2.93e-07 | 472 | 186 | 14 | 38943005 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 3.19e-07 | 167 | 186 | 9 | 20362541 | |
| Pubmed | 3.29e-07 | 83 | 186 | 7 | 28794006 | ||
| Pubmed | HCN3 CAMSAP3 DBN1 MCOLN1 MECP2 MXRA7 SHANK2 AJM1 G3BP2 KBTBD11 MACF1 TNKS1BP1 | 4.25e-07 | 347 | 186 | 12 | 17114649 | |
| Pubmed | Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation. | 6.00e-07 | 4 | 186 | 3 | 19221051 | |
| Pubmed | 6.00e-07 | 4 | 186 | 3 | 21248248 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 6.00e-07 | 4 | 186 | 3 | 23129768 | |
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 6.29e-07 | 31 | 186 | 5 | 20516061 | |
| Pubmed | SATB2 KMT2B RAPH1 CDK12 FNBP4 ZBTB9 ZNF318 DBN1 ZYX TGFB2 UBE2O PRCC YLPM1 SON | 6.71e-07 | 506 | 186 | 14 | 30890647 | |
| Pubmed | 1.13e-06 | 251 | 186 | 10 | 31076518 | ||
| Pubmed | 1.37e-06 | 16 | 186 | 4 | 23870121 | ||
| Pubmed | 1.37e-06 | 16 | 186 | 4 | 24368734 | ||
| Pubmed | 1.49e-06 | 5 | 186 | 3 | 21550664 | ||
| Pubmed | 1.53e-06 | 104 | 186 | 7 | 10470851 | ||
| Pubmed | CDCA3 DLG5 APBB1 PPP1R13B ZNF318 C6orf132 UBE2O LPP MACF1 PLEKHA7 | 1.72e-06 | 263 | 186 | 10 | 34702444 | |
| Pubmed | RALGDS ZNF219 HIGD2A KMT2B RBP3 ZNF629 IRF3 SRPK2 TACC2 BCAR1 RAX NCOR1 NCOR2 PTPN12 TXNDC5 KBTBD11 CCAR2 IGSF9 ROBO3 | 2.19e-06 | 1006 | 186 | 19 | 15226823 | |
| Pubmed | PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. | 2.29e-06 | 18 | 186 | 4 | 17500065 | |
| Pubmed | ZBTB2 ZNF219 ZNF629 ZBTB9 SRPK2 ZC3H18 ZNF318 BOD1L2 MECP2 FBXL6 NCOR2 SOWAHA RASAL3 ZNF608 CTCF MACF1 FKBP8 ZNF687 SON ZNF574 | 2.58e-06 | 1116 | 186 | 20 | 31753913 | |
| Pubmed | KIF13B ZBTB2 RNPC3 ZNF629 DGKD ANO8 PRR12 PWWP2A KRBA1 MYO15B MACF1 NEURL4 MED12 | 2.88e-06 | 493 | 186 | 13 | 15368895 | |
| Pubmed | 2.97e-06 | 6 | 186 | 3 | 19028691 | ||
| Pubmed | 2.97e-06 | 6 | 186 | 3 | 24096085 | ||
| Pubmed | Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock. | 2.97e-06 | 6 | 186 | 3 | 22761364 | |
| Pubmed | Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. | 2.97e-06 | 6 | 186 | 3 | 17021013 | |
| Pubmed | IRF3 and type I interferons fuel a fatal response to myocardial infarction. | 2.97e-06 | 6 | 186 | 3 | 29106401 | |
| Pubmed | 2.97e-06 | 6 | 186 | 3 | 25320282 | ||
| Pubmed | 2.97e-06 | 6 | 186 | 3 | 28564605 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RAPH1 CDK12 APBB1 TACC2 ZNF318 DBN1 ZYX UBE2O PTPN12 MAVS CTCF PRCC LPP YLPM1 MACF1 TNKS1BP1 HCFC1 SON | 3.11e-06 | 934 | 186 | 18 | 33916271 |
| Pubmed | SHANK1 DOCK4 BCL9L KIAA0513 CAMSAP3 APBB1 TACC2 DBN1 ANO8 UBE2O SHANK2 TXNDC5 ABI2 AJM1 G3BP2 MACF1 DCLK2 KIF2A FKBP8 WNK2 | 3.50e-06 | 1139 | 186 | 20 | 36417873 | |
| Pubmed | 3.78e-06 | 119 | 186 | 7 | 23508102 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | TRERF1 ZBTB2 PWWP2A NCOR1 NCOR2 TXNDC5 YLPM1 CCAR2 ZNF687 SON | 3.97e-06 | 289 | 186 | 10 | 23752268 |
| Pubmed | STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. | 5.19e-06 | 7 | 186 | 3 | 25517615 | |
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 28630094 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 30267576 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 30604749 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 11867749 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 19556342 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ZBTB2 ZNF219 RBL2 ZBTB9 IRF3 E2F4 BARX2 MECP2 RAX NCOR2 ZNF263 ZNF276 AEBP1 MZF1 TOX3 SPEN HCFC1 | 5.48e-06 | 877 | 186 | 17 | 20211142 |
| Pubmed | 6.48e-06 | 23 | 186 | 4 | 9225980 | ||
| Pubmed | 7.23e-06 | 50 | 186 | 5 | 37974198 | ||
| Pubmed | 8.26e-06 | 8 | 186 | 3 | 24278020 | ||
| Pubmed | The TLR3/TICAM-1 pathway is mandatory for innate immune responses to poliovirus infection. | 8.26e-06 | 8 | 186 | 3 | 21998457 | |
| Pubmed | 8.26e-06 | 8 | 186 | 3 | 30319350 | ||
| Pubmed | Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. | 8.26e-06 | 8 | 186 | 3 | 23770565 | |
| Pubmed | BCL9L SETD1A ZC3H18 MECP2 KMT2C KMT2D PTPN12 PELP1 CCAR2 TNKS1BP1 SPEN HCFC1 | 9.46e-06 | 469 | 186 | 12 | 27634302 | |
| Pubmed | 1.19e-05 | 94 | 186 | 6 | 16325481 | ||
| Pubmed | ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response. | 1.23e-05 | 9 | 186 | 3 | 19416887 | |
| Pubmed | 1.23e-05 | 9 | 186 | 3 | 19017982 | ||
| Pubmed | VISA is an adapter protein required for virus-triggered IFN-beta signaling. | 1.23e-05 | 9 | 186 | 3 | 16153868 | |
| Pubmed | An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation. | 1.23e-05 | 9 | 186 | 3 | 12007404 | |
| Pubmed | 1.23e-05 | 9 | 186 | 3 | 11782456 | ||
| Pubmed | Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression. | 1.23e-05 | 9 | 186 | 3 | 16951254 | |
| Pubmed | Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. | 1.23e-05 | 9 | 186 | 3 | 25636800 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 1.26e-05 | 330 | 186 | 10 | 33301849 | |
| Pubmed | SHANK1 RALGDS ZNF142 PPP1R13B CRTC1 CBLB ZYX KMT2C RASAL3 MACF1 OS9 WNK2 | 1.35e-05 | 486 | 186 | 12 | 20936779 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.45e-05 | 146 | 186 | 7 | 23892456 | |
| Pubmed | 1.47e-05 | 28 | 186 | 4 | 29365100 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | SETD1A KMT2B TROAP FBXL17 E2F4 FBXL6 PWWP2A KMT2C UBE2O KMT2D SOWAHA HCFC1 | 1.61e-05 | 495 | 186 | 12 | 27705803 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CDK12 CCDC174 FNBP4 ZBTB9 ZC3H18 ZNF318 DBN1 MECP2 NCOR1 NCOR2 PELP1 CTCF PRCC YLPM1 SPEN HCFC1 SON | 1.62e-05 | 954 | 186 | 17 | 36373674 |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 1.64e-05 | 59 | 186 | 5 | 28813667 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | LRSAM1 CAMSAP3 FNBP4 KMT2C KRBA1 XIRP2 KIF2A FKBP8 HCFC1 MED12 WNK4 ZNF687 | 1.68e-05 | 497 | 186 | 12 | 36774506 |
| Pubmed | Molecular regulation of H3K4 trimethylation by Wdr82, a component of human Set1/COMPASS. | 1.76e-05 | 10 | 186 | 3 | 18838538 | |
| Pubmed | FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands. | 1.76e-05 | 10 | 186 | 3 | 9171351 | |
| Pubmed | Analysis of BCL6-interacting proteins by tandem mass spectrometry. | 2.10e-05 | 62 | 186 | 5 | 16147992 | |
| Pubmed | Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. | 2.41e-05 | 11 | 186 | 3 | 11331609 | |
| Pubmed | Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. | 2.41e-05 | 11 | 186 | 3 | 20975040 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.63e-05 | 220 | 186 | 8 | 35785414 | |
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 11013137 | ||
| Pubmed | Notch3 promotes prostate cancer-induced bone lesion development via MMP-3. | 2.84e-05 | 2 | 186 | 2 | 31467432 | |
| Interaction | NUP43 interactions | BCL9L SETD1A EME1 KMT2B CDK12 ZBTB9 E2F4 ZC3H18 ZNF318 MECP2 SMTN NCOR1 NCOR2 KMT2D MAVS ZNF608 PELP1 NFATC2IP CTCF RECQL4 TOX3 CCAR2 KIF2A SPEN HCFC1 MED12 ZNF687 SON | 1.46e-12 | 625 | 178 | 28 | int:NUP43 |
| Interaction | SP7 interactions | TRERF1 BCL9L SATB2 KMT2B ZNF318 CBLB PRR12 NCOR1 KMT2C NCOR2 KMT2D ZNF608 NKX2-4 PRCC YLPM1 HOMEZ | 1.31e-08 | 304 | 178 | 16 | int:SP7 |
| Interaction | LHX4 interactions | BCL9L SATB2 ZBTB2 BOD1L2 NCOR1 KMT2C NCOR2 KMT2D TXNDC5 ABI2 ZNF687 ZNF574 | 2.91e-08 | 166 | 178 | 12 | int:LHX4 |
| Interaction | HDAC1 interactions | TRERF1 SATB2 ZBTB2 ZNF219 KMT2B RAPH1 RBL2 CAMSAP3 APBB1 ZBTB9 CRTC1 E2F4 ZNF318 MECP2 PWWP2A NCOR1 NCOR2 KMT2D ZNF608 CTCF RECQL4 PHLPP1 AFF1 CCAR2 TNKS1BP1 KIF2A SPEN HCFC1 MED12 ZNF687 | 3.89e-08 | 1108 | 178 | 30 | int:HDAC1 |
| Interaction | TOP3B interactions | SEMA6C SETD1A KMT2B KIAA0513 CDK12 TRIM41 EMID1 SMG5 ANO8 MXRA7 C6orf132 FBXL6 PRR12 NCOR1 KMT2C NCOR2 ZNF263 KMT2D ZNF276 SHANK2 PELP1 NISCH G3BP2 KBTBD11 AHSG TNKS1BP1 GNAS SLC45A1 SPEN MMP17 HCFC1 MED12 WNK2 ZNF687 ARAP1 | 6.01e-08 | 1470 | 178 | 35 | int:TOP3B |
| Interaction | CRX interactions | TRERF1 BCL9L SATB2 BOD1L2 PRR12 KMT2C NCOR2 KMT2D MYO15B ZNF608 ABI2 SPEN MED12 HOMEZ | 6.19e-08 | 254 | 178 | 14 | int:CRX |
| Interaction | TBR1 interactions | BCL9L SATB2 PRR12 NCOR1 KMT2C NCOR2 KMT2D ZNF608 NKX2-4 RECQL4 | 6.35e-08 | 113 | 178 | 10 | int:TBR1 |
| Interaction | NUP50 interactions | SETD1A CDK12 DUSP4 FNBP4 ZNF629 SRPK2 ZNF318 MECP2 FBXL6 NCOR1 SOWAHA PRCC NISCH RECQL4 SPEN SON | 6.47e-08 | 341 | 178 | 16 | int:NUP50 |
| Interaction | SNRNP40 interactions | BCL9L KMT2B CDK12 RNPC3 ZBTB9 SRPK2 ZC3H18 ZNF318 MECP2 NCOR1 NCOR2 ZNF608 PELP1 NFATC2IP CTCF PRCC G3BP2 CCAR2 SPEN MED12 SON | 2.27e-07 | 637 | 178 | 21 | int:SNRNP40 |
| Interaction | EGR2 interactions | TRERF1 BCL9L ZBTB9 PRR12 NCOR1 KMT2C NCOR2 KMT2D ZNF608 HCFC1 HOMEZ | 3.64e-07 | 171 | 178 | 11 | int:EGR2 |
| Interaction | VASP interactions | RAPH1 APBB1 PPP1R13B CRTC1 DBN1 ZYX C6orf132 AEBP1 XIRP2 ABI2 LPP TNKS1BP1 FBLIM1 APBB1IP | 3.72e-07 | 294 | 178 | 14 | int:VASP |
| Interaction | NCK2 interactions | FAM47A RAPH1 GGN TRIM41 SRPK2 BCAR1 CBLB PTPN12 ABI2 SSH3 YLPM1 ARAP1 HOMEZ | 6.19e-07 | 262 | 178 | 13 | int:NCK2 |
| Interaction | PAX2 interactions | 8.53e-07 | 85 | 178 | 8 | int:PAX2 | |
| Interaction | TBXT interactions | 9.05e-07 | 116 | 178 | 9 | int:TBXT | |
| Interaction | MEN1 interactions | KIF13B SETD1A KMT2B FNBP4 ZNF629 SRPK2 ZC3H18 ARHGEF17 CBLB FBXL6 PRR12 NCOR1 KMT2C KMT2D ZNF608 PELP1 CTCF PRCC G3BP2 YLPM1 TNKS1BP1 SPEN HCFC1 MED12 ZNF687 SON | 1.30e-06 | 1029 | 178 | 26 | int:MEN1 |
| Interaction | FEV interactions | SETD1A SATB2 KMT2B PRR12 NCOR1 KMT2C NCOR2 KMT2D ZNF608 CTCF HOMEZ | 1.98e-06 | 203 | 178 | 11 | int:FEV |
| Interaction | SOX17 interactions | 2.00e-06 | 95 | 178 | 8 | int:SOX17 | |
| Interaction | TERF2IP interactions | SETD1A ZBTB2 KMT2B CDK12 E2F4 ZC3H18 ZNF318 ZNF414 NCOR1 NCOR2 ZNF608 NFATC2IP CTCF PRCC RECQL4 SPEN HCFC1 ZNF687 | 2.04e-06 | 552 | 178 | 18 | int:TERF2IP |
| Interaction | ARHGAP12 interactions | 2.29e-06 | 68 | 178 | 7 | int:ARHGAP12 | |
| Interaction | PAX9 interactions | 2.35e-06 | 130 | 178 | 9 | int:PAX9 | |
| Interaction | PPIA interactions | CDCA3 DCAF15 DLG5 RAPH1 CDK12 CCDC174 DUSP4 APBB1 SRPK2 E2F4 ZC3H18 MECP2 SMTN MAVS CTCF PRCC RECQL4 NECTIN2 MACF1 HCFC1 MED12 NOTCH3 ZNF687 | 3.76e-06 | 888 | 178 | 23 | int:PPIA |
| Interaction | TEAD1 interactions | 3.84e-06 | 176 | 178 | 10 | int:TEAD1 | |
| Interaction | SETD1B interactions | 4.46e-06 | 75 | 178 | 7 | int:SETD1B | |
| Interaction | NFIB interactions | 4.87e-06 | 142 | 178 | 9 | int:NFIB | |
| Interaction | LHX2 interactions | 5.44e-06 | 183 | 178 | 10 | int:LHX2 | |
| Interaction | FBXO22 interactions | LRSAM1 CAMSAP3 FNBP4 BCAR1 NCOR1 KMT2C NCOR2 KRBA1 XIRP2 RECQL4 PHLPP1 KIF2A FKBP8 HCFC1 MED12 WNK4 ZNF687 | 6.34e-06 | 540 | 178 | 17 | int:FBXO22 |
| Interaction | HNF4A interactions | SETD1A SATB2 KMT2B ZNF629 ZBTB9 PRR12 NCOR1 KMT2C NCOR2 KMT2D ZNF608 SPEN | 6.37e-06 | 275 | 178 | 12 | int:HNF4A |
| Interaction | PAX8 interactions | 6.44e-06 | 111 | 178 | 8 | int:PAX8 | |
| Interaction | ZNF768 interactions | 8.04e-06 | 151 | 178 | 9 | int:ZNF768 | |
| Interaction | HDAC2 interactions | SATB2 ZBTB2 ZNF219 CCDC174 IRF3 ZC3H18 ZNF318 MECP2 ZYX PWWP2A NCOR1 NCOR2 ZNF263 TXNDC5 PELP1 G3BP2 RECQL4 LPP TNKS1BP1 SPEN HCFC1 ZNF687 | 8.29e-06 | 865 | 178 | 22 | int:HDAC2 |
| Interaction | SRSF6 interactions | CASC3 CDK12 RNPC3 DUSP4 ZNF629 SRPK2 E2F4 ZC3H18 MECP2 UBE2O CTCF ZNF358 RECQL4 SPEN SON ZNF574 | 1.06e-05 | 503 | 178 | 16 | int:SRSF6 |
| Interaction | TLX3 interactions | BCL9L SATB2 DBN1 PRR12 NCOR1 KMT2C NCOR2 KMT2D ZNF608 CCAR2 APBB1IP HOMEZ | 1.13e-05 | 291 | 178 | 12 | int:TLX3 |
| Interaction | GSC interactions | 1.20e-05 | 87 | 178 | 7 | int:GSC | |
| Interaction | HCFC1 interactions | SETD1A KMT2B E2F4 NCOR1 KMT2C UBE2O KMT2D ZNF608 PELP1 RECQL4 PHLPP1 HCFC1 | 1.21e-05 | 293 | 178 | 12 | int:HCFC1 |
| Interaction | CEBPA interactions | TRERF1 SATB2 KMT2B CCDC174 ZNF629 ZBTB9 E2F4 ZNF318 ZNF414 MECP2 ZYX TGFB2 PRR12 NCOR1 KMT2C NCOR2 KMT2D TXNDC5 G3BP2 MACF1 CCAR2 KIF2A SPEN HCFC1 MED12 ZNF687 HOMEZ | 1.35e-05 | 1245 | 178 | 27 | int:CEBPA |
| Interaction | CDH1 interactions | CDCA3 DLG5 RAPH1 PPP1R13B DBN1 BCAR1 ZYX C6orf132 SHANK2 MAVS ZNF608 SSH3 LPP NECTIN2 PHLPP1 MACF1 TNKS1BP1 PLEKHA7 HCFC1 NOTCH3 | 1.57e-05 | 768 | 178 | 20 | int:CDH1 |
| Interaction | LBR interactions | ZBTB2 FNBP4 SRPK2 ZC3H18 ARHGEF17 MECP2 FBXL6 UBE2O CTCF MZF1 RECQL4 FKBP8 | 1.74e-05 | 304 | 178 | 12 | int:LBR |
| Interaction | TRIM52 interactions | 2.42e-05 | 133 | 178 | 8 | int:TRIM52 | |
| Interaction | MYB interactions | 2.42e-05 | 133 | 178 | 8 | int:MYB | |
| Interaction | NOTCH2 interactions | ZNF142 ZNF219 SCARF2 ZNF629 ZBTB9 FBXL17 ZYX ZNF263 ZNF276 ZNF358 SPEN NOTCH3 ZNF687 ZNF574 | 2.49e-05 | 423 | 178 | 14 | int:NOTCH2 |
| Interaction | NANOG interactions | TRERF1 BNC2 SATB2 ZBTB2 ZNF219 KMT2B NCOR1 KMT2C NCOR2 PTPN12 PELP1 G3BP2 CCAR2 HCFC1 MED12 | 2.54e-05 | 481 | 178 | 15 | int:NANOG |
| Interaction | TLX1 interactions | 2.62e-05 | 175 | 178 | 9 | int:TLX1 | |
| Interaction | KDM1A interactions | TRERF1 DLG5 SATB2 KMT2B RAPH1 CAMSAP3 ZBTB9 CRTC1 E2F4 ZNF318 PRR12 NCOR1 NCOR2 KMT2D ZNF608 PELP1 RECQL4 ATF7IP2 TNKS1BP1 MED12 ZNF687 HOMEZ | 3.03e-05 | 941 | 178 | 22 | int:KDM1A |
| Interaction | TLE3 interactions | TRERF1 BCL9L CDK12 ZNF318 TGFB2 PRR12 NCOR1 NCOR2 KMT2D ZNF608 TNKS1BP1 SPEN SON | 3.12e-05 | 376 | 178 | 13 | int:TLE3 |
| Interaction | RCOR1 interactions | SATB2 KMT2B RAPH1 CAMSAP3 ZBTB9 ZNF318 MECP2 NCOR1 NCOR2 KMT2D RECQL4 TNKS1BP1 SPEN MED12 ZNF687 | 3.45e-05 | 494 | 178 | 15 | int:RCOR1 |
| Interaction | NFIX interactions | SETD1A SATB2 KMT2B PRR12 NCOR1 KMT2C NCOR2 KMT2D ZNF608 SPEN | 3.53e-05 | 227 | 178 | 10 | int:NFIX |
| Interaction | BAG2 interactions | BORCS6 KIF13B SETD1A FNBP4 PPP1R13B E2F4 ZNF318 FBXL6 NCOR1 MAVS RECQL4 PHLPP1 CCAR2 SPINDOC SPEN MED12 NOTCH3 | 3.88e-05 | 622 | 178 | 17 | int:BAG2 |
| Interaction | TLX2 interactions | 3.88e-05 | 142 | 178 | 8 | int:TLX2 | |
| Interaction | RBBP5 interactions | SETD1A KMT2B MECP2 SMTN KMT2C KMT2D PELP1 RECQL4 CCAR2 SPEN HCFC1 | 5.13e-05 | 287 | 178 | 11 | int:RBBP5 |
| Interaction | GUSBP5 interactions | 5.30e-05 | 75 | 178 | 6 | int:GUSBP5 | |
| Interaction | EN1 interactions | 5.52e-05 | 110 | 178 | 7 | int:EN1 | |
| Interaction | SRSF4 interactions | ZBTB2 CDK12 TICAM1 ZNF629 SRPK2 ZC3H18 MECP2 CTCF RECQL4 SON ZNF574 | 7.62e-05 | 300 | 178 | 11 | int:SRSF4 |
| Interaction | ASF1A interactions | 7.67e-05 | 249 | 178 | 10 | int:ASF1A | |
| Interaction | SORBS3 interactions | 8.00e-05 | 202 | 178 | 9 | int:SORBS3 | |
| Interaction | SOX7 interactions | 8.76e-05 | 82 | 178 | 6 | int:SOX7 | |
| Interaction | PPP1CC interactions | RAPH1 CDK12 CAMSAP3 ZNF629 APBB1 PPP1R13B TACC2 ZC3H18 ZNF318 DBN1 MECP2 PRR12 NCOR1 UBE2O RECQL4 YLPM1 HCFC1 SON | 9.85e-05 | 738 | 178 | 18 | int:PPP1CC |
| Interaction | WWTR1 interactions | RAPH1 CDK12 APBB1 PPP1R13B ZNF318 DBN1 ZYX NCOR1 UBE2O KMT2D LPP TNKS1BP1 HCFC1 | 1.01e-04 | 422 | 178 | 13 | int:WWTR1 |
| Interaction | YAP1 interactions | TRERF1 BCL9L SETD1A KMT2B CDK12 FNBP4 IRF3 ZNF318 DBN1 ZYX TGM1 NCOR1 KMT2C UBE2O KMT2D YLPM1 TNKS1BP1 GNAS SPINDOC SPEN HCFC1 MED12 TMEM139 | 1.02e-04 | 1095 | 178 | 23 | int:YAP1 |
| Interaction | PHF20 interactions | 1.03e-04 | 53 | 178 | 5 | int:PHF20 | |
| Interaction | IRF4 interactions | 1.07e-04 | 85 | 178 | 6 | int:IRF4 | |
| Interaction | YWHAH interactions | DOCK4 KIF13B CASC3 DLG5 CAMSAP3 ZNF629 APBB1 CRTC1 BCAR1 ARHGEF17 C6orf132 ABI2 RECQL4 LPP NECTIN2 MACF1 CCAR2 TNKS1BP1 DCLK2 KIF2A PLEKHA7 WNK2 HOMEZ | 1.12e-04 | 1102 | 178 | 23 | int:YWHAH |
| Interaction | PAX7 interactions | 1.18e-04 | 124 | 178 | 7 | int:PAX7 | |
| Interaction | WDR82 interactions | 1.20e-04 | 213 | 178 | 9 | int:WDR82 | |
| Interaction | C8orf33 interactions | 1.22e-04 | 167 | 178 | 8 | int:C8orf33 | |
| Interaction | E2F2 interactions | 1.24e-04 | 55 | 178 | 5 | int:E2F2 | |
| Interaction | SMG7 interactions | ZNF318 SMG5 ZYX PRR12 TGM1 NCOR1 NCOR2 UBE2O KMT2D ZNF608 YLPM1 | 1.31e-04 | 319 | 178 | 11 | int:SMG7 |
| Interaction | SHANK3 interactions | SHANK1 BCL9L ZNF318 DBN1 PRRT2 ZNF263 SHANK2 XIRP2 ABI2 MACF1 IGSF9 KIF2A FKBP8 NOTCH3 | 1.37e-04 | 496 | 178 | 14 | int:SHANK3 |
| Interaction | NKTR interactions | 1.47e-04 | 90 | 178 | 6 | int:NKTR | |
| Interaction | NOLC1 interactions | ZBTB2 CDK12 RNPC3 SRPK2 E2F4 ZC3H18 MECP2 UBE2O PELP1 G3BP2 MED12 | 1.54e-04 | 325 | 178 | 11 | int:NOLC1 |
| Interaction | ZNF24 interactions | 1.61e-04 | 174 | 178 | 8 | int:ZNF24 | |
| Interaction | MTDH interactions | DCAF15 KMT2B ZC3H18 DBN1 MAP3K12 MECP2 CTCF MRC2 SSH3 G3BP2 RECQL4 FKBP8 WNK2 NOTCH3 | 1.65e-04 | 505 | 178 | 14 | int:MTDH |
| Interaction | C6orf141 interactions | 1.66e-04 | 92 | 178 | 6 | int:C6orf141 | |
| Interaction | HCFC2 interactions | 1.66e-04 | 92 | 178 | 6 | int:HCFC2 | |
| Interaction | FOXI1 interactions | 1.66e-04 | 92 | 178 | 6 | int:FOXI1 | |
| Interaction | CXXC1 interactions | 1.74e-04 | 132 | 178 | 7 | int:CXXC1 | |
| Interaction | PFN1 interactions | DOCK4 DLG5 RAPH1 SRPK2 ZC3H18 DBN1 C6orf132 RECQL4 LPP PHLPP1 MACF1 TNKS1BP1 KIF2A APBB1IP | 1.79e-04 | 509 | 178 | 14 | int:PFN1 |
| Interaction | RAB5A interactions | CDCA3 MTSS1 CAMSAP3 APBB1 DBN1 PRRT2 ZYX MXRA7 NCOR1 PTPN12 MAVS NISCH RECQL4 NECTIN2 MACF1 CCAR2 NEURL4 | 1.80e-04 | 706 | 178 | 17 | int:RAB5A |
| Interaction | FOXK2 interactions | 1.81e-04 | 225 | 178 | 9 | int:FOXK2 | |
| Interaction | ASCL2 interactions | 1.82e-04 | 13 | 178 | 3 | int:ASCL2 | |
| Interaction | AR interactions | TRERF1 BCL9L ZBTB9 E2F4 ZNF318 PRR12 NCOR1 KMT2C NCOR2 KMT2D TXNDC5 ZNF608 PELP1 NFATC2IP NISCH YLPM1 CCAR2 GNAS HCFC1 MED12 SON | 1.87e-04 | 992 | 178 | 21 | int:AR |
| Interaction | TNRC6A interactions | 2.00e-04 | 280 | 178 | 10 | int:TNRC6A | |
| Interaction | MAPRE3 interactions | 2.13e-04 | 230 | 178 | 9 | int:MAPRE3 | |
| Interaction | ELP4 interactions | 2.19e-04 | 62 | 178 | 5 | int:ELP4 | |
| Interaction | SOX9 interactions | 2.22e-04 | 97 | 178 | 6 | int:SOX9 | |
| Interaction | FHIP2B interactions | 2.22e-04 | 34 | 178 | 4 | int:FHIP2B | |
| Interaction | BUB3 interactions | 2.27e-04 | 232 | 178 | 9 | int:BUB3 | |
| Interaction | LHX3 interactions | 2.45e-04 | 185 | 178 | 8 | int:LHX3 | |
| Interaction | YWHAZ interactions | KIF13B DLG5 RAPH1 CAMSAP3 ZNF629 CRTC1 TACC2 ZC3H18 BCAR1 C6orf132 ITPKA NCOR1 RASAL3 ABI2 PRCC SSH3 NISCH RECQL4 NECTIN2 MACF1 CCAR2 KIF2A PLEKHA7 WNK2 HOMEZ | 2.47e-04 | 1319 | 178 | 25 | int:YWHAZ |
| Interaction | YWHAB interactions | DOCK4 KIF13B CASC3 DLG5 CAMSAP3 ZNF629 CRTC1 SRPK2 BCAR1 ARHGEF17 ZYX C6orf132 ABI2 RECQL4 NECTIN2 MACF1 DCLK2 KIF2A PLEKHA7 HOMEZ SON | 2.51e-04 | 1014 | 178 | 21 | int:YWHAB |
| Interaction | DHX8 interactions | 2.80e-04 | 292 | 178 | 10 | int:DHX8 | |
| Interaction | CREBBP interactions | TRERF1 SETD1A ZBTB2 RBL2 IRF3 CRTC1 TACC2 TGM1 NCOR1 NCOR2 KMT2D SOWAHA PELP1 NISCH CCAR2 | 2.89e-04 | 599 | 178 | 15 | int:CREBBP |
| Interaction | YWHAE interactions | KIF13B DLG5 CDK12 CAMSAP3 ZNF629 CRTC1 TACC2 ZC3H18 DBN1 BCAR1 ZYX C6orf132 NCOR2 UBE2O RASAL3 ABI2 NISCH RECQL4 MACF1 CCAR2 DCLK2 SPINDOC PLEKHA7 WNK2 | 2.95e-04 | 1256 | 178 | 24 | int:YWHAE |
| Interaction | FMR1 interactions | CASC3 ZBTB2 ZNF219 SRPK2 DGKD E2F4 TACC2 NCOR1 NCOR2 NISCH G3BP2 MACF1 CCAR2 KIF2A | 3.02e-04 | 536 | 178 | 14 | int:FMR1 |
| Interaction | LHX1 interactions | 3.07e-04 | 103 | 178 | 6 | int:LHX1 | |
| Interaction | ANKMY2 interactions | 3.15e-04 | 67 | 178 | 5 | int:ANKMY2 | |
| Interaction | SOX2 interactions | TRERF1 BCL9L DLG5 SATB2 CDK12 JPH2 SRPK2 DBN1 MECP2 PRR12 NCOR1 KMT2C NCOR2 KMT2D ZNF608 PELP1 CTCF G3BP2 YLPM1 AHSG MACF1 CCAR2 KIF2A SPEN ZNF687 HOMEZ | 3.22e-04 | 1422 | 178 | 26 | int:SOX2 |
| Interaction | NCK1 interactions | 3.30e-04 | 244 | 178 | 9 | int:NCK1 | |
| Interaction | GCM1 interactions | 3.38e-04 | 68 | 178 | 5 | int:GCM1 | |
| Interaction | KLF5 interactions | 3.49e-04 | 195 | 178 | 8 | int:KLF5 | |
| Interaction | SAFB2 interactions | 3.49e-04 | 195 | 178 | 8 | int:SAFB2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | DCAF15 BEST2 TICAM1 CAMSAP3 CRTC1 MCOLN1 ZNF414 ANO8 RASAL3 ZFR2 ZNF358 FKBP8 NOTCH3 | 2.52e-05 | 797 | 186 | 13 | chr19p13 |
| Cytoband | 16p11.2 | 1.37e-04 | 191 | 186 | 6 | 16p11.2 | |
| Cytoband | 2q33 | 2.21e-04 | 29 | 186 | 3 | 2q33 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | BNC2 ZBTB2 ZNF142 ZNF219 ZNF629 ZBTB9 ZNF205 ZNF318 ZNF414 ZNF263 ZNF276 ZNF608 CTCF MZF1 ZNF358 ZFHX2 ZNF574 | 8.18e-06 | 718 | 124 | 17 | 28 |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.38e-05 | 25 | 124 | 4 | 775 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 8.34e-05 | 34 | 124 | 4 | 487 | |
| GeneFamily | Sterile alpha motif domain containing | 3.48e-04 | 88 | 124 | 5 | 760 | |
| GeneFamily | LIM domain containing | 7.17e-04 | 59 | 124 | 4 | 1218 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 2.03e-03 | 10 | 124 | 2 | 1178 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.98e-03 | 206 | 124 | 6 | 682 | |
| Coexpression | GSE11924_TFH_VS_TH2_CD4_TCELL_UP | BCL9L TRIM41 CRTC1 ZC3H18 NFATC2IP PRCC NISCH NEURL4 ZNF687 ARAP1 | 1.46e-06 | 200 | 182 | 10 | M3153 |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | PERM1 DGKD ARHGEF17 SMTN TGFB2 PRELP MRC2 MMP17 CTDSPL NOTCH3 | 1.06e-08 | 200 | 182 | 10 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-08 | 187 | 182 | 9 | 976b74d081b7fba8620768613cc26f9262cd7b16 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.40e-07 | 161 | 182 | 8 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.40e-07 | 161 | 182 | 8 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.40e-07 | 161 | 182 | 8 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-07 | 175 | 182 | 8 | d2ff8fedca9039cbd45cfd9dec88f4edbe7fe4fc | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-07 | 175 | 182 | 8 | a7310950e8d51b3004ea3aee8ce9948fe8655112 | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-06 | 191 | 182 | 8 | 51cff0594ac7ad8c065c8ea2301f8c149bd062b4 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-06 | 191 | 182 | 8 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-06 | 191 | 182 | 8 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-06 | 191 | 182 | 8 | a55b6f0a7ec1a8852ffca593cfdccd7edea09b7b | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-06 | 191 | 182 | 8 | 38681a1b182d6af5cce85db5431b6eba4b20ad96 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-06 | 192 | 182 | 8 | 1b228f0929b505de82a39bf64c837887b0e56701 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-06 | 194 | 182 | 8 | aaecde88bd54134a938e76cdf059c1c2653e4e77 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-06 | 196 | 182 | 8 | 4740ef6e428f1ccc81fc98c3b868afd38ce60535 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-06 | 198 | 182 | 8 | 705118a5db366b43ffd3389c60e4cb392ad3f2e6 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-06 | 199 | 182 | 8 | ad75e5e26c37a97331164d7f77235ebd9a933a44 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.75e-06 | 200 | 182 | 8 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-06 | 151 | 182 | 7 | ea62e92ccb984f44559b434f35c1c4450767c8f1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.70e-06 | 156 | 182 | 7 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.86e-06 | 157 | 182 | 7 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-06 | 159 | 182 | 7 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-06 | 175 | 182 | 7 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.87e-06 | 175 | 182 | 7 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.87e-06 | 175 | 182 | 7 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | severe_influenza-Plasmablast|World / disease group, cell group and cell class (v2) | 7.87e-06 | 175 | 182 | 7 | e6d6c44510d5dc4eb0bae820125e42366f7a4e74 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-06 | 175 | 182 | 7 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 176 | 182 | 7 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 176 | 182 | 7 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.80e-06 | 178 | 182 | 7 | 8bae5db100f4563aa1fc7f881e7f8c59d669e37a | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.80e-06 | 178 | 182 | 7 | bc0336692b84bd0fa49747ed5a031b8ed8afa0fd | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.80e-06 | 178 | 182 | 7 | cda7695411655bd6d0ba69e5041ca7530a9dad3a | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.12e-06 | 179 | 182 | 7 | f5bb4d3a27d56698473219970e764084096cc582 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-06 | 179 | 182 | 7 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.12e-06 | 179 | 182 | 7 | fa03ec3cc0132f977b4cb28e7b23789732375183 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-06 | 179 | 182 | 7 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 180 | 182 | 7 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 180 | 182 | 7 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.81e-06 | 181 | 182 | 7 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.81e-06 | 181 | 182 | 7 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 182 | 182 | 7 | 9edaccf1154cec92ca9a28e9b1f9075cfd422bfd | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 182 | 182 | 7 | aba4c06d5d7618ac21b2695bca8e7a1346a91090 | |
| ToppCell | P03-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.05e-05 | 183 | 182 | 7 | 89727b4f65949ed2dce9d2e0228c79fe4280230c | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 183 | 182 | 7 | 0f02136359787bd78146617990968baa47a65d86 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 183 | 182 | 7 | 2f0dcc65ad4d90ef946919b4462280fdd20c5ea0 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.05e-05 | 183 | 182 | 7 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | P03-Endothelial-lymphatic_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.05e-05 | 183 | 182 | 7 | 113e6d8d4bb271be984af06cd6c22b180425dcfc | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 185 | 182 | 7 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-05 | 187 | 182 | 7 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Endothelial-G|World / shred on cell class and cell subclass (v4) | 1.21e-05 | 124 | 182 | 6 | 4b72809463f2986b7d1b7ab9de633ac4d7854a92 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 189 | 182 | 7 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 190 | 182 | 7 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | ILEUM-non-inflamed-(8)_Activated_fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.34e-05 | 190 | 182 | 7 | 39fa110d19c97c7cac99f5fb91b26bc08e2f3b42 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 191 | 182 | 7 | 9c5d88f0d3c834c2419ec3da74652175153ba9df | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 191 | 182 | 7 | 1efb47743b6834b64cb0f61721ddbe875b1a66ca | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 191 | 182 | 7 | a7494191a92984e5f53610bbbedd6714e9169e1c | |
| ToppCell | (210)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.44e-05 | 192 | 182 | 7 | 08dc0c019c594da7b9944db8fd706aa7780e6ae9 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 192 | 182 | 7 | 5e6f8206ee0b10cdba79a7c4a05452cb025a5512 | |
| ToppCell | droplet-Lung-30m-Mesenchymal|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-05 | 192 | 182 | 7 | 5d5bec238b196f0b3e727fd94f078d6ae524cb01 | |
| ToppCell | (21)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.44e-05 | 192 | 182 | 7 | b0a573ddde2978485a857b8261ee1ee5ef68ecef | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.44e-05 | 192 | 182 | 7 | 0afb9dbe468e0be442c326e11c5fc0f699b32f23 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 192 | 182 | 7 | 136af0186c70c14c5f2b33ed7a148156de5b478c | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 192 | 182 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 194 | 182 | 7 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|World / Lineage and Cell class | 1.54e-05 | 194 | 182 | 7 | c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 194 | 182 | 7 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-05 | 195 | 182 | 7 | 7155cc12cc6a97efd626bbdb95249fb3d7041dcf | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-05 | 195 | 182 | 7 | a52ee3ad6cd317f10b9308450517861ef2e363bb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-05 | 195 | 182 | 7 | b3660779f274ca97dd844cf83f62d85ba88cb182 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 195 | 182 | 7 | 717e6a66bad50e711442d71360b540789646b334 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-05 | 195 | 182 | 7 | 56e7cd980f8fc2dae842e6a7bd919d4b41cebbbb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 195 | 182 | 7 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 195 | 182 | 7 | 3969b8d5fcec8ef1831531a781f7bbcebab5a4ba | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 195 | 182 | 7 | 10774b5ce17d4edd23dbf4709b11cc87cc2b87be | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-05 | 195 | 182 | 7 | a28a504c69bc4dda7de023e1b4ea4f62390b158e | |
| ToppCell | (5)_Fibroblast-K_(Pericytes)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.64e-05 | 196 | 182 | 7 | e3c89c5bd674289738d5590ebfd30c605f5156a5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 196 | 182 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 196 | 182 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 196 | 182 | 7 | 184104cbea0461dd2757668ab9755948ac7b585a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 196 | 182 | 7 | bebb20dc210576101c317011e3afb59798f5d255 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 196 | 182 | 7 | 8c25fa61c117a60ddd4cbd2f95ae5b66f986a1ec | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 196 | 182 | 7 | 208ddedd29e1b9ca89cbb9b527c2e193a44cada2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 196 | 182 | 7 | 8114e98923096c54b6834f21550c3061bab6773d | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.64e-05 | 196 | 182 | 7 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-05 | 197 | 182 | 7 | 01249bd485a3734de87ae6ed9c749597f39c6335 | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-05 | 197 | 182 | 7 | da653dc7d216e202f390e5ab0245f243e3ed213b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-05 | 197 | 182 | 7 | 78d45d11820ec379942c4c3defd619d5f8cc8e1f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-05 | 197 | 182 | 7 | 31bc9fd679d78550541d4158568e8dd09ff29e8e | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-05 | 132 | 182 | 6 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | distal-2-mesenchymal-Vascular_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-05 | 198 | 182 | 7 | ce05ede69c167b2294630709bb0c223483a6ef75 | |
| ToppCell | facs-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-05 | 198 | 182 | 7 | e85ae846e293687fd193f4d565525d8d3bd1faea | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-05 | 198 | 182 | 7 | c82a151f9f1477d4a401457173b8d72af776c137 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-05 | 198 | 182 | 7 | dc63b56bb6291e527b172d603569376286262845 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-05 | 199 | 182 | 7 | 9a08c25bb4851ad4ac9db8916422280f71378c2c | |
| ToppCell | medial-mesenchymal-Vascular_Smooth_Muscle|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.81e-05 | 199 | 182 | 7 | 74fe1737a0d63ef0bc49312f1b5823b5c39590dd | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-05 | 199 | 182 | 7 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | medial-2-mesenchymal-Vascular_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.81e-05 | 199 | 182 | 7 | 8ce0bcc53b3a955285d614459e45210104a6ed02 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Smooth_Muscle_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 1.81e-05 | 199 | 182 | 7 | ffb871dc3d232a7bdc2d55d91b76e79883e8fa1b | |
| ToppCell | medial-mesenchymal-Vascular_Smooth_Muscle-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.81e-05 | 199 | 182 | 7 | 263603264ff40ea8ef569cb43f8b84b5938438ab | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; MCF7; HT_HG-U133A | BORCS6 KIF13B SETD1A TICAM1 CRTC1 E2F4 ARHGEF17 ITPKA SMTN TGFB2 ZNF358 ZFHX2 FKBP8 CTDSPL | 5.61e-10 | 197 | 179 | 14 | 3413_UP |
| Drug | Esculetin [305-01-1]; Down 200; 22.4uM; HL60; HT_HG-U133A | 3.47e-06 | 195 | 179 | 10 | 3120_DN | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A | SETD1A RALGDS KIAA0513 ZYX SSH3 ZNF358 YLPM1 ATF7IP2 MMP3 NOTCH3 | 3.80e-06 | 197 | 179 | 10 | 4295_DN |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 3.98e-06 | 198 | 179 | 10 | 3537_DN | |
| Drug | staurosporine; Up 200; 0.1uM; MCF7; HG-U133A | 1.11e-05 | 176 | 179 | 9 | 423_UP | |
| Drug | Forskolin, from Coleus forskohlii; Up 200; 0.5uM; PC3; HT_HG-U133A | 1.87e-05 | 188 | 179 | 9 | 7104_UP | |
| Drug | Bisacodyl [603-50-9]; Down 200; 11uM; PC3; HT_HG-U133A | 2.30e-05 | 193 | 179 | 9 | 4616_DN | |
| Drug | Delcorine; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.40e-05 | 194 | 179 | 9 | 4275_DN | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 2.50e-05 | 195 | 179 | 9 | 5571_DN | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.50e-05 | 195 | 179 | 9 | 3530_DN | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.60e-05 | 196 | 179 | 9 | 7226_DN | |
| Drug | Sulfathiazole [72-14-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 2.60e-05 | 196 | 179 | 9 | 4769_DN | |
| Drug | Colistin sulfate [1264-72-8]; Up 200; 3uM; HL60; HT_HG-U133A | 2.60e-05 | 196 | 179 | 9 | 2491_UP | |
| Drug | copper(II) sulfate pentahydrate; Up 200; 100uM; MCF7; HG-U133A | 2.71e-05 | 197 | 179 | 9 | 438_UP | |
| Drug | Meprylcaine hydrochloride [956-03-6]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.71e-05 | 197 | 179 | 9 | 3544_DN | |
| Drug | Deoxycorticosterone [64-85-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.71e-05 | 197 | 179 | 9 | 5357_UP | |
| Drug | rapamycin; Down 200; 0.1uM; HL60; HG-U133A | 2.71e-05 | 197 | 179 | 9 | 362_DN | |
| Drug | Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.71e-05 | 197 | 179 | 9 | 3335_DN | |
| Drug | alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.71e-05 | 197 | 179 | 9 | 3877_DN | |
| Drug | Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A | 2.71e-05 | 197 | 179 | 9 | 3417_DN | |
| Drug | Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.82e-05 | 198 | 179 | 9 | 3259_DN | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.82e-05 | 198 | 179 | 9 | 5816_DN | |
| Drug | Theophylline monohydrate [5967-84-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 2.82e-05 | 198 | 179 | 9 | 4812_UP | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.93e-05 | 199 | 179 | 9 | 7295_DN | |
| Drug | Meropenem [96036-03-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.93e-05 | 199 | 179 | 9 | 3564_DN | |
| Drug | colchicine; Up 200; 0.1uM; MCF7; HG-U133A | 3.05e-05 | 200 | 179 | 9 | 644_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 3.05e-05 | 200 | 179 | 9 | 6970_UP | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 3.05e-05 | 200 | 179 | 9 | 3425_UP | |
| Drug | poly(I-C | 6.45e-05 | 171 | 179 | 8 | CID000213546 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 6.72e-05 | 172 | 179 | 8 | 7073_DN | |
| Drug | resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 7.90e-05 | 176 | 179 | 8 | 958_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 8.89e-05 | 179 | 179 | 8 | 331_DN | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 1.12e-04 | 185 | 179 | 8 | 5439_DN | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.25e-04 | 188 | 179 | 8 | 5493_UP | |
| Drug | ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 1.25e-04 | 188 | 179 | 8 | 974_UP | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.39e-04 | 191 | 179 | 8 | 5351_DN | |
| Drug | thapsigargin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.39e-04 | 191 | 179 | 8 | 7100_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.39e-04 | 191 | 179 | 8 | 3855_DN | |
| Drug | vinblastine sulfate; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.44e-04 | 192 | 179 | 8 | 7556_UP | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A | 1.44e-04 | 192 | 179 | 8 | 4330_DN | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.50e-04 | 193 | 179 | 8 | 4285_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.50e-04 | 193 | 179 | 8 | 6223_UP | |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.50e-04 | 193 | 179 | 8 | 3627_DN | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.50e-04 | 193 | 179 | 8 | 4286_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A | 1.50e-04 | 193 | 179 | 8 | 4338_DN | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.55e-04 | 194 | 179 | 8 | 4828_UP | |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 1.55e-04 | 194 | 179 | 8 | 5362_UP | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 1.55e-04 | 194 | 179 | 8 | 1670_DN | |
| Drug | Dimenhydrinate [523-87-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.55e-04 | 194 | 179 | 8 | 5450_DN | |
| Drug | W-13, hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 1.55e-04 | 194 | 179 | 8 | 440_UP | |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.55e-04 | 194 | 179 | 8 | 6066_DN | |
| Drug | 5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA | 1.55e-04 | 194 | 179 | 8 | 828_UP | |
| Drug | Acemetacin [53164-05-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.61e-04 | 195 | 179 | 8 | 5460_DN | |
| Drug | Atovaquone [95233-18-4]; Down 200; 11uM; PC3; HT_HG-U133A | 1.61e-04 | 195 | 179 | 8 | 4201_DN | |
| Drug | Thiamphenicol [15318-45-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.61e-04 | 195 | 179 | 8 | 1704_DN | |
| Drug | deferoxamine mesylate salt; Down 200; 100uM; MCF7; HG-U133A | 1.61e-04 | 195 | 179 | 8 | 573_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.66e-04 | 196 | 179 | 8 | 3742_DN | |
| Drug | Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 1.66e-04 | 196 | 179 | 8 | 7470_DN | |
| Drug | SR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.66e-04 | 196 | 179 | 8 | 3272_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.66e-04 | 196 | 179 | 8 | 5438_DN | |
| Drug | Lovastatin [75330-75-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.66e-04 | 196 | 179 | 8 | 4978_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.66e-04 | 196 | 179 | 8 | 6260_UP | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; HL60; HT_HG-U133A | 1.66e-04 | 196 | 179 | 8 | 2351_DN | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.66e-04 | 196 | 179 | 8 | 5827_DN | |
| Drug | Aceclofenac [89796-99-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.66e-04 | 196 | 179 | 8 | 7029_DN | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.66e-04 | 196 | 179 | 8 | 5533_UP | |
| Drug | Isocarboxazid [59-63-2]; Up 200; 17.2uM; HL60; HT_HG-U133A | 1.66e-04 | 196 | 179 | 8 | 2562_UP | |
| Drug | Phenindione [83-12-5]; Up 200; 18uM; HL60; HG-U133A | 1.72e-04 | 197 | 179 | 8 | 1718_UP | |
| Drug | Methiazole; Down 200; 15uM; PC3; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 4532_DN | |
| Drug | TTNPB; Up 200; 0.1uM; PC3; HG-U133A | 1.72e-04 | 197 | 179 | 8 | 451_UP | |
| Drug | Alfaxalone [23930-19-0]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 6514_UP | |
| Drug | Alprostadil [745-65-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 7358_DN | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 7500_UP | |
| Drug | Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 5317_UP | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 4829_DN | |
| Drug | Solasodine [126-17-0]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 2170_DN | |
| Drug | Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 7231_DN | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 2779_UP | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.72e-04 | 197 | 179 | 8 | 1468_DN | |
| Drug | rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.78e-04 | 198 | 179 | 8 | 914_DN | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; HL60; HT_HG-U133A | 1.78e-04 | 198 | 179 | 8 | 2356_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HG-U133A | 1.78e-04 | 198 | 179 | 8 | 347_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.78e-04 | 198 | 179 | 8 | 6498_DN | |
| Drug | Propidium iodide [25535-16-4]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.78e-04 | 198 | 179 | 8 | 6104_DN | |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.78e-04 | 198 | 179 | 8 | 6505_DN | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 1.78e-04 | 198 | 179 | 8 | 6992_UP | |
| Drug | Danazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.78e-04 | 198 | 179 | 8 | 1538_UP | |
| Drug | Sulfinpyrazone [57-96-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.78e-04 | 198 | 179 | 8 | 6230_UP | |
| Drug | Tolazamide [1156-19-0]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.78e-04 | 198 | 179 | 8 | 2842_DN | |
| Drug | Tetrandrine [518-34-3]; Down 200; 6.4uM; PC3; HT_HG-U133A | 1.85e-04 | 199 | 179 | 8 | 5821_DN | |
| Drug | Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.85e-04 | 199 | 179 | 8 | 7203_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HG-U133A | 1.85e-04 | 199 | 179 | 8 | 418_DN | |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.85e-04 | 199 | 179 | 8 | 7433_DN | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.85e-04 | 199 | 179 | 8 | 6968_DN | |
| Drug | Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 1.85e-04 | 199 | 179 | 8 | 7237_DN | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; HL60; HG-U133A | 1.85e-04 | 199 | 179 | 8 | 1436_UP | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 1.85e-04 | 199 | 179 | 8 | 5509_UP | |
| Drug | Calciferol [50-14-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.85e-04 | 199 | 179 | 8 | 5346_DN | |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; PC3; HT_HG-U133A | 1.85e-04 | 199 | 179 | 8 | 7250_UP | |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.85e-04 | 199 | 179 | 8 | 5781_DN | |
| Disease | Malignant neoplasm of breast | TRERF1 RAPH1 SCARF2 TICAM1 TACC2 ZNF318 DBN1 BCAR1 MCOLN1 FSCB NCOR1 KMT2D NISCH G3BP2 NECTIN2 TOX3 SLC6A5 AFF1 MACF1 MMP3 SPEN MED12 NOTCH3 | 9.83e-08 | 1074 | 174 | 23 | C0006142 |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 3.46e-05 | 2 | 174 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | cardiovascular disease biomarker measurement, internal carotid intimal medial thickness | 3.46e-05 | 2 | 174 | 2 | EFO_0005053, EFO_0005278 | |
| Disease | congenital heart disease (implicated_via_orthology) | 5.58e-05 | 69 | 174 | 5 | DOID:1682 (implicated_via_orthology) | |
| Disease | Intellectual Disability | SETD1A RALGDS ZNF142 PRRT2 MECP2 PRR12 KMT2C SHANK2 CTCF MACF1 GNAS | 7.52e-05 | 447 | 174 | 11 | C3714756 |
| Disease | skin neoplasm | 7.80e-05 | 74 | 174 | 5 | EFO_0004198 | |
| Disease | serine palmitoyltransferase 1 measurement | 1.03e-04 | 3 | 174 | 2 | EFO_0803055 | |
| Disease | Malignant Cystosarcoma Phyllodes | 3.42e-04 | 5 | 174 | 2 | C0600066 | |
| Disease | Herpetic Acute Necrotizing Encephalitis | 3.42e-04 | 5 | 174 | 2 | C0001338 | |
| Disease | Phyllodes Tumor | 3.42e-04 | 5 | 174 | 2 | C0010701 | |
| Disease | Herpetic meningoencephalitis | 5.11e-04 | 6 | 174 | 2 | C0019385 | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 5.11e-04 | 6 | 174 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | response to surgery, post-operative sign or symptom | 5.11e-04 | 6 | 174 | 2 | EFO_0005323, EFO_0009951 | |
| Disease | testosterone measurement | DOCK4 CASC3 SATB2 ZNF219 SPEM3 EMID1 FNBP4 ZNF629 ZNF318 TGFB2 NCOR2 NISCH DGKK AFF1 MACF1 TNKS1BP1 MED12 ARAP1 | 5.64e-04 | 1275 | 174 | 18 | EFO_0004908 |
| Disease | Autism spectrum disorder | 7.12e-04 | 7 | 174 | 2 | cv:C1510586 | |
| Disease | Herpes encephalitis | 7.12e-04 | 7 | 174 | 2 | C0276226 | |
| Disease | Mental Retardation, X-Linked 1 | 8.81e-04 | 32 | 174 | 3 | C2931498 | |
| Disease | macula measurement | 9.26e-04 | 189 | 174 | 6 | EFO_0008375 | |
| Disease | cognitive disorder (biomarker_via_orthology) | 9.46e-04 | 8 | 174 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | FEV/FEC ratio | BNC2 SCARF2 EMID1 FBXL17 CRTC1 DGKD ARHGEF17 SMTN TGFB2 PRR12 CTCF MRC2 YLPM1 LRRC37B TNXB ARAP1 ATP6V0A2 | 9.97e-04 | 1228 | 174 | 17 | EFO_0004713 |
| Disease | Mammary Neoplasms | TRERF1 NCOR1 KMT2D CTCF NISCH NECTIN2 TOX3 MMP3 MED12 NOTCH3 | 1.21e-03 | 527 | 174 | 10 | C1458155 |
| Disease | corticobasal degeneration disorder | 1.21e-03 | 9 | 174 | 2 | MONDO_0022308 | |
| Disease | Liver Diseases, Parasitic | 1.21e-03 | 9 | 174 | 2 | C0023897 | |
| Disease | Profound Mental Retardation | 1.43e-03 | 139 | 174 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.43e-03 | 139 | 174 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.43e-03 | 139 | 174 | 5 | C0917816 | |
| Disease | total blood protein measurement | 1.45e-03 | 449 | 174 | 9 | EFO_0004536 | |
| Disease | Pseudohypoaldosteronism, Type I | 1.51e-03 | 10 | 174 | 2 | C0268436 | |
| Disease | Pseudohypoaldosteronism | 1.51e-03 | 10 | 174 | 2 | C0033805 | |
| Disease | RETINITIS PIGMENTOSA | 1.51e-03 | 10 | 174 | 2 | 268000 | |
| Disease | Hyperpotassemia and Hypertension, Familial | 1.51e-03 | 10 | 174 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 1.51e-03 | 10 | 174 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 1.51e-03 | 10 | 174 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 1.51e-03 | 10 | 174 | 2 | C1449842 | |
| Disease | pulse pressure measurement | BNC2 RAPH1 JPH2 FBXL17 ZNF318 BCAR1 MXRA7 ADRA1D ABI2 MRC2 LPP ROBO3 SPINDOC PLEKHA7 HCFC1 MAP4K2 NOTCH3 HOMEZ | 1.52e-03 | 1392 | 174 | 18 | EFO_0005763 |
| Disease | Thyroid preparation use measurement | 1.87e-03 | 217 | 174 | 6 | EFO_0009933 | |
| Disease | Cleft palate, isolated | 1.95e-03 | 42 | 174 | 3 | C1837218 | |
| Disease | brain disease (is_implicated_in) | 2.19e-03 | 12 | 174 | 2 | DOID:936 (is_implicated_in) | |
| Disease | Craniofacial Abnormalities | 2.37e-03 | 156 | 174 | 5 | C0376634 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.38e-03 | 45 | 174 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Squamous cell carcinoma of esophagus | 2.45e-03 | 95 | 174 | 4 | C0279626 | |
| Disease | colon carcinoma (is_marker_for) | 2.58e-03 | 13 | 174 | 2 | DOID:1520 (is_marker_for) | |
| Disease | Impaired cognition | 3.00e-03 | 14 | 174 | 2 | C0338656 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.04e-03 | 49 | 174 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | response to fenofibrate | 3.22e-03 | 50 | 174 | 3 | GO_1901557 | |
| Disease | Prostatic Neoplasms | CDK12 BCAR1 NCOR1 KMT2C KMT2D TXNDC5 CTCF NECTIN2 SPEN MED12 | 3.72e-03 | 616 | 174 | 10 | C0033578 |
| Disease | nervousness | 3.93e-03 | 16 | 174 | 2 | NCIT_C74532 | |
| Disease | Mammary Carcinoma, Human | 4.11e-03 | 525 | 174 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 4.11e-03 | 525 | 174 | 9 | C1257931 | |
| Disease | Diffuse Large B-Cell Lymphoma | 4.22e-03 | 55 | 174 | 3 | C0079744 | |
| Disease | S-adenosylhomocysteine measurement | 4.44e-03 | 17 | 174 | 2 | EFO_0010531 | |
| Disease | sex interaction measurement, ulcerative colitis | 4.44e-03 | 17 | 174 | 2 | EFO_0000729, EFO_0008343 | |
| Disease | R-6-hydroxywarfarin measurement | 4.71e-03 | 114 | 174 | 4 | EFO_0803327 | |
| Disease | Breast Carcinoma | 4.81e-03 | 538 | 174 | 9 | C0678222 | |
| Disease | breast cancer (is_marker_for) | 4.91e-03 | 185 | 174 | 5 | DOID:1612 (is_marker_for) | |
| Disease | cognitive function measurement | RBL2 MTSS1 ZBTB9 FBXL17 SRPK2 BARX2 DBN1 PRR12 ADRA1D KMT2D ZNF608 NFATC2IP PHLPP1 HS3ST3B1 TNXB WNK2 ARAP1 | 4.95e-03 | 1434 | 174 | 17 | EFO_0008354 |
| Disease | body surface area | 5.01e-03 | 643 | 174 | 10 | EFO_0022196 | |
| Disease | keratinocyte carcinoma | 5.32e-03 | 118 | 174 | 4 | EFO_0010176 | |
| Disease | platelet component distribution width | MTSS1 ZNF629 PWWP2A NCOR2 UBE2O MAVS LPP MACF1 KIF2A GNAS TNXB | 5.36e-03 | 755 | 174 | 11 | EFO_0007984 |
| Disease | abnormal paneth cell measurement | 5.53e-03 | 19 | 174 | 2 | EFO_0007963 | |
| Disease | serum non-albumin protein measurement | 5.77e-03 | 361 | 174 | 7 | EFO_0004568 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DLPEAPPPPLEPAVI | 496 | Q8N163 | |
| EAPPPAGPEPLTLIP | 461 | Q8NFU1 | |
| PPPPPLVEGDLSSAP | 1276 | Q9NYV4 | |
| EPPAQSSTEPPAEPP | 341 | Q9NZN9 | |
| EIEPEPEPQPVTPAP | 631 | P49711 | |
| PPPDSPPAEDVYDVP | 351 | P56945 | |
| PPAEDVYDVPPPAPD | 356 | P56945 | |
| IEQHPPPPSEPVVPA | 601 | Q6ZN30 | |
| EDDVEAPPPPEPTPR | 51 | Q8IUX7 | |
| AVPALPPEPEGQDPP | 151 | Q8IYS8 | |
| LPPPPPEPLSQEEEE | 141 | Q7Z5R6 | |
| TLPEPPPPESAVPRA | 66 | C9J069 | |
| PPGLPEPLESVEAPP | 176 | O00213 | |
| AAPAPAPAPTPTPEE | 91 | Q8N531 | |
| PTQPPPEPGDLPTIE | 446 | Q9P1Y5 | |
| ELPPAQPTAPLPAEP | 771 | Q96KQ4 | |
| NPVSDTPPPPPPVEE | 396 | Q9NYB9 | |
| PPVEEPVFDESPPPP | 406 | Q9NYB9 | |
| PLPPTSDPLETPAPS | 1201 | Q9HCE9 | |
| LPPEPVLPPEAPLSS | 106 | Q99618 | |
| LEPEPELEPPTPQIP | 111 | Q86YV0 | |
| ELEPPTPQIPEAPTP | 116 | Q86YV0 | |
| SDFPPPPPETELPLP | 1071 | Q70E73 | |
| APVGPRSPPPDEEDP | 26 | A6NKC0 | |
| PEAPTSSPLEAPPPV | 16 | O60268 | |
| AGPSPAPPTPPEEED | 26 | Q9GZU1 | |
| PFLGPLPTDPPAEEP | 406 | Q12851 | |
| LPTDPPAEEPLSSPP | 411 | Q12851 | |
| PPPPPPAAAASDEEE | 11 | Q08999 | |
| VPEPPTSVGPPVAVP | 971 | Q96PE2 | |
| APVGPRSPPPDEEDP | 26 | A8MXZ1 | |
| TPVPGPSVPPPEELQ | 1491 | P51610 | |
| PSVPPPEELQVSPGP | 1496 | P51610 | |
| EPVSPPSPPHTDPEL | 146 | Q9Y618 | |
| PSPPHTDPELELVPP | 151 | Q9Y618 | |
| PPEDIPAPTEPTPAS | 786 | Q9Y618 | |
| PAPPLLSEASPEPIP | 41 | Q5KSL6 | |
| PTPEPATEPASEPAP | 81 | Q5KSL6 | |
| SEPAPEPATEPAPEP | 91 | Q5KSL6 | |
| PEPAPEPATESAPEP | 111 | Q5KSL6 | |
| TPEPALESVPEPAPE | 126 | Q5KSL6 | |
| APELAPEPTPEPVTE | 146 | Q5KSL6 | |
| PEPTPEPVTELAPEF | 151 | Q5KSL6 | |
| VRTTPPEPPPFEDQP | 571 | Q9BR39 | |
| PEPPPFEDQPEPEVS | 576 | Q9BR39 | |
| PSESPPPELPPPEAA | 766 | A5PL33 | |
| PQPPAPTPAPELEEL | 301 | Q9H2Z4 | |
| PTPAPELEELSPSPP | 306 | Q9H2Z4 | |
| EEPPEPVPSPIIPIL | 4026 | Q8NEZ4 | |
| PEEQSPEVPDSPSPI | 111 | Q9Y662 | |
| DRPPDPLEPPSLPAE | 101 | Q7Z434 | |
| QPPPAEEAPAEVQPP | 611 | Q5H9T9 | |
| PPAEEAPAEVQPPPA | 661 | Q5H9T9 | |
| APQEPPESVRPSAPP | 651 | Q6UWE0 | |
| PPDSPETPLVPTEPV | 266 | P08254 | |
| ETPLVPTEPVPPEPG | 271 | P08254 | |
| EEIPVPGEAVPAPTP | 726 | Q8N568 | |
| PGEAVPAPTPPESPT | 731 | Q8N568 | |
| EDAFDALPPSLPPPP | 811 | Q13191 | |
| LPQEAPATEPAPPPA | 31 | Q96B70 | |
| PTVPDLPGVLPAPPD | 621 | O43312 | |
| APLPPSPLPPSVDDN | 306 | E9PQR5 | |
| FVPLPPSPLPPSVDD | 326 | E9PQR5 | |
| GEPLEPPEPSVPLLP | 1631 | Q9UM47 | |
| APAPEPPAEEPRLEP | 576 | Q96MW5 | |
| SPPSALPPDVDPGEP | 1046 | Q8TDM6 | |
| PTPEEPTSPAAAVPP | 1021 | O94854 | |
| PTSPAAAVPPPEEPT | 1026 | O94854 | |
| DFLPPPPPPLDDSSA | 66 | Q93052 | |
| PPPSQEREPPAEPSI | 576 | Q8N423 | |
| PVTPELPGPDPTPSL | 651 | Q9UBG0 | |
| TTDPPPEHPEVTLPP | 386 | Q96QE4 | |
| PLPLPPEDEEPPAPT | 1741 | Q93074 | |
| AEAAVTIPKPEPPPP | 241 | Q9UMN6 | |
| LPSPPPPPAQEEQEE | 441 | Q9UMN6 | |
| PPPAQEEQEESPPPV | 446 | Q9UMN6 | |
| PITTSPPVPQEPAPV | 566 | Q9UMN6 | |
| LTPPPLGAPEAPEPE | 666 | Q9UMN6 | |
| LGAPEAPEPEPPPAD | 671 | Q9UMN6 | |
| LDEVTSSQPPPLPPP | 356 | Q16643 | |
| PPEEAAAVSAPPPAP | 86 | Q86UU5 | |
| TPGLEAVPPVAPPPA | 16 | Q9P1Z3 | |
| APSGTPPPTIPPDET | 741 | Q8IZL8 | |
| EVEEGAPPPPTLPPA | 971 | Q8IZL8 | |
| PVIPEVPFEPSKPPV | 6 | Q9BW72 | |
| AEEPDVPPTSPGPPE | 86 | P23677 | |
| TAVPLSDPPPPPSEA | 531 | Q0D2I5 | |
| QEVETRAVPSPPPPP | 1016 | Q96JP2 | |
| APVGPSAPPPDEEDP | 26 | A6NJQ4 | |
| EIEPSPETPPPPASS | 71 | O00139 | |
| LESAAPPEPAPEPAP | 126 | Q7Z6L0 | |
| IPPPPEFSNDPEPPA | 986 | Q5T0Z8 | |
| IPDPDDFVPPVPPPS | 136 | Q15884 | |
| PEPPLHPVVPDLPSS | 196 | Q5EBM0 | |
| EPSEPSAPLPAGVPP | 6 | Q14318 | |
| APTPTPAIPPIDPEV | 246 | Q96GS4 | |
| AAPDAAPPPPDRPIE | 386 | O15234 | |
| AEEVPPPPEGLIPAP | 421 | O15234 | |
| SSPPVAVPVPPPEDL | 201 | Q16254 | |
| EQSAPLPVPVPVPVP | 1871 | Q8N1I0 | |
| SPLPTPLDPEEPTFP | 256 | Q6UUV9 | |
| EAPPPSSPSVLPPLV | 56 | O15194 | |
| EAVPTPVVDPDAPPS | 266 | P02765 | |
| PVVDPDAPPSPPLGA | 271 | P02765 | |
| TTPPPAEPVSLPQEP | 226 | Q9UN86 | |
| PEEEPPLSPPPRDGA | 76 | Q9UF56 | |
| PPDPPQELPIPSSEP | 261 | Q9UMQ3 | |
| LPSAPLPDPPAPAES | 76 | A0A0U1RRI6 | |
| SAPPALPPEGPPEDS | 316 | Q86UU0 | |
| VPESFEHLPPLPEPP | 546 | Q5U623 | |
| DPPPSEVIPGPEPSS | 801 | Q12852 | |
| PEPEPAPTPAPGSEL | 291 | Q12967 | |
| PPPPPPEESSDSEPE | 16 | Q16760 | |
| PPPPPVLDGEDVLPD | 86 | Q8WUP2 | |
| PPETPVSHLLPEPPE | 191 | Q5JRC9 | |
| VIGPLPPEPEAVPTP | 321 | Q6PII3 | |
| PPEPEAVPTPRPAAQ | 326 | Q6PII3 | |
| CPPAPELFSPPVPEI | 56 | Q96AY2 | |
| EQPVPPTPATPEDPA | 161 | Q96A84 | |
| EVPPPPVPAPEQVGI | 151 | Q8IX15 | |
| AEPLPPEPPAVPSEV | 291 | I6L899 | |
| AIPPPVPPSATEPLD | 166 | Q13115 | |
| SLPLPPSPPVLPEEG | 341 | Q9Y2W3 | |
| APLPPSPLPPSVDDN | 306 | E9PJ23 | |
| FVPLPPSPLPPSVDD | 326 | E9PJ23 | |
| DPVPAPIPGDPVPIS | 641 | Q5SV97 | |
| ASPPEPQSPELPPAL | 281 | Q66K64 | |
| PIPTPPLEPLAPTED | 216 | Q96JN8 | |
| PLPDPGPPSLAVAPE | 151 | Q14653 | |
| LPPPPPEPESSEDPT | 386 | P51608 | |
| PEPESSEDPTSPPEP | 391 | P51608 | |
| PISHPPPPTAVPAEE | 1606 | Q9NQT8 | |
| PPPPPGELARSPEAV | 71 | Q96N64 | |
| EEPPLPQPVAPALVP | 131 | Q96N64 | |
| EEEDLDPVTPLPPPP | 161 | Q8WV44 | |
| PTVPEELPPGTEPEP | 296 | Q92733 | |
| EEPDPEPPPVTPQVG | 431 | Q9UPR3 | |
| PEQELPAAAAPPPPR | 36 | Q9Y345 | |
| PPPPPPAEDGEIQEV | 726 | Q8N3X1 | |
| SPTAQPEEPPLLPEP | 301 | Q9ULZ9 | |
| PEEPPLLPEPPDNRS | 306 | Q9ULZ9 | |
| EPLVPSPQPVPEVPS | 431 | O94761 | |
| PSPEIQAADPPTPRP | 531 | Q5JWF2 | |
| LPPPPEPISTEPVET | 611 | O75376 | |
| EEILQPPEPHPVPPI | 351 | Q05209 | |
| PEDQPPAVPPLPREA | 931 | Q6IQ23 | |
| PREEAPPPPPPTEDS | 596 | Q9UPW6 | |
| DPDPEPPSPDSPTET | 241 | Q9BUA3 | |
| FPQPDEPAEPTDLPP | 46 | P51888 | |
| APLAAPPEEPAAPSP | 1521 | Q9ULL5 | |
| VEVEPPEPPGPVASR | 71 | Q8NCF5 | |
| SAIEVVPAPEPPPAT | 1171 | O15047 | |
| DPASPEEPGEPAPVP | 116 | O94819 | |
| PPPSPQPTEEDPEHR | 526 | Q13438 | |
| APEEGSEPSPPPAPA | 76 | Q9Y2V3 | |
| PDTSEDIPPPPQSVP | 881 | Q9UPX8 | |
| GSEDIPPPPTTSPPE | 916 | Q9Y566 | |
| PEVSTPFPPLPPEPE | 491 | Q8TE77 | |
| EPLETPAPEPEPPTT | 496 | P51825 | |
| PLALTALPDPDPEPP | 461 | P25100 | |
| TPSTAAPDPVLPPLP | 131 | Q96P48 | |
| IPPQTPPETPSPDET | 866 | A8K7I4 | |
| TEAADVPPPVPAPPT | 246 | Q8N5U0 | |
| SLSENELPPPPEPPG | 16 | Q9BTX7 | |
| TSPPEDYPEPEEVPP | 51 | P61812 | |
| NASSEIEFPLPPPPP | 2126 | A4UGR9 | |
| EPPAPERPPEVDPAS | 216 | Q96IQ9 | |
| LEEEPPQDVPPHAPP | 546 | Q9UPR6 | |
| NLTPEASPDPLPEPP | 1091 | Q9C0A1 | |
| EEAPPPPPAVPSPEE | 711 | P10745 | |
| PTSPQPPEEPPLPDE | 221 | Q96LT9 | |
| SDPVTPPSDPSIPIP | 2456 | Q96T58 | |
| PVPDPVPATTPAPII | 416 | A0A1B0GUW6 | |
| LPAAPPPSAVPLEPS | 296 | Q2M3V2 | |
| ELPSSPPPGLPEVAP | 266 | Q8IUC6 | |
| PTVPAEAPAPSPVPL | 581 | Q96GP6 | |
| DLPPPPLPPPEEEAS | 1266 | Q96MS0 | |
| PTTPVPPEEPVIGFP | 421 | Q6ZN55 | |
| PPEEPVIGFPEPAPA | 426 | Q6ZN55 | |
| PLPDPTPPEPEEEIL | 36 | P78362 | |
| APEAPRPSSPPPEVL | 361 | Q9C0C2 | |
| PSPTEPSMEAPEPPE | 2396 | P22105 | |
| TPAPTEPSTEAPEPP | 2936 | P22105 | |
| TPAPELAPEAPEPPE | 3541 | P22105 | |
| VPEETPVEAPAPPPA | 1086 | Q9Y2I1 | |
| PVEAPAPPPAEAPAQ | 1091 | Q9Y2I1 | |
| EEPPIPPLEQPVAPE | 756 | Q9C0C9 | |
| AEPPPGPPSPSVTTE | 591 | Q8N554 | |
| EVPEPCPPAEPRPLE | 576 | Q12815 | |
| TTFLPPPEGVPPPEL | 681 | Q9H3T2 | |
| PPPEVIPEPEVSTQP | 1971 | O95359 | |
| IPEPEVSTQPPPEEP | 1976 | O95359 | |
| IPPITPPPESDPALG | 66 | O15405 | |
| APELAPEAPEPPEEP | 31 | Q16473 | |
| EDISPVAPPPAAPPS | 901 | Q9P2J2 | |
| QVPESPSSEEPPLPP | 341 | P49750 | |
| PSSEEPPLPPPNEEV | 346 | P49750 | |
| ESAPLELPAPPALPP | 266 | Q96C00 | |
| PDAAPPDPSPTEPQE | 261 | O95201 | |
| EKVDPLFTVPAPPPP | 301 | Q9ULD9 | |
| PPPPIEESFPPAPLE | 96 | Q15942 | |
| PAPLEEEIFPSPPPP | 106 | Q15942 | |
| EEIFPSPPPPPEEEG | 111 | Q15942 | |
| EPVTPEPEVEPPSAP | 171 | Q8NBS9 | |
| SEEEEVPSSPEPPRP | 926 | Q8N1G0 | |
| AEPPPEAGPRLAPPE | 261 | O60346 | |
| PLSPPPEAPPLESAE | 296 | P35713 | |
| PLQPPTTPSPEPEPE | 16 | P22735 | |
| LVSTPVPPPPPGEET | 206 | Q8N680 | |
| TPPAETAPLPPLPES | 786 | P52746 | |
| ALPDLPTATVPPVPP | 816 | Q9Y3S1 | |
| HPAPEAPESSPPLPL | 1321 | Q9Y3S1 | |
| PLDPPAPEVVPTPSD | 91 | Q9UEG4 | |
| SEPSHLPEQILPPPP | 1431 | Q5VUA4 | |
| EEPAPLPALPVPLPD | 766 | Q96J92 | |
| LTAEVPGSPEPPPSP | 226 | P53814 | |
| LPPEEPPEGPALPTE | 1171 | P18583 | |
| VSEAAVTVPEPPPEP | 1241 | P18583 | |
| PPPYSTVVIPPAPEE | 111 | Q8IV31 | |
| PEPEPEPEREATPTP | 246 | Q9P2Y4 | |
| ATPTPAPAAPEEPPA | 256 | Q9P2Y4 | |
| APAAPEEPPAPPEFR | 261 | Q9P2Y4 | |
| EILPPPPPEPPTESA | 286 | Q86VM9 | |
| DIPLPEGEASPPAPP | 76 | Q9Y487 | |
| LVPSPDLDPVPSPDP | 506 | Q9NW07 | |
| DLDPVPSPDPDPVPS | 511 | Q9NW07 | |
| SPEPPPVPVLAPTEG | 986 | Q96PN7 | |
| QELPPPDPGPSPEAS | 26 | O14978 | |
| PLPPEPPAVPSEVEL | 286 | A6NN73 | |
| LPPPEESPLSPPPEE | 441 | O14686 | |
| PPEASRLSPPPEELP | 461 | O14686 | |
| ESPLSPPPEESPLSP | 491 | O14686 | |
| EESPLSPPEESPPSP | 516 | O14686 | |
| SPPEESPPSPALETP | 521 | O14686 | |
| LSPPPEASPLSPPFE | 536 | O14686 | |
| SPPFEESPLSPPPEE | 546 | O14686 | |
| ESPLSPPPEELPTSP | 551 | O14686 | |
| PPPEELPTSPPPEAS | 556 | O14686 | |
| PPFEESPLSPPPEES | 601 | O14686 | |
| PEESPLSPPPEESPT | 666 | O14686 | |
| PPPEDSPTSPPPEDS | 691 | O14686 | |
| PPEDSPASPPPEDSL | 701 | O14686 | |
| APEELPLFPPPGEPS | 876 | O14686 | |
| LPTEPLAEPPVPSPL | 4936 | O14686 | |
| EPARAPPEPAPPAEA | 36 | P84157 | |
| SFQPLPETEPPTPEP | 151 | P28698 | |
| SPIPVPPGPPAVEDV | 476 | Q92692 |